All Access Fund
All Access Fund 2025

Sigma Genetics Inc.

About Sigma Genetics Inc.

Sigma Genetics is building the next-generation platform for intracellular delivery, enabling scalable, high-efficiency cell engineering across therapeutics and biomanufacturing. Our magnetoporation technology unlocks new possibilities in immunotherapies, blood products, and synthetic biology, paving the way for faster, safer, and more cost-effective cell-based solutions. We aim to become the foundational delivery engine powering the future of cell and gene therapy.